NanoEcho’s technology is presented at a surgeon conference
Images generated with NanoEcho’s system were shown for the first time to internationally leading colorectal surgeons at the annual Swedish conference on colorectal surgery.
NanoEcho strengthens management by hiring a clinical director
NanoEcho strengthens the organization by hiring Ulrika Axelsson as responsible for the company’s clinical operations. Ulrika will be part of the company’s executive management team and will, among other things, be responsible for planning and carrying out the company’s clinical studies, with the goal of getting market approval for NanoEcho’s system for rectal cancer diagnostics.
Start of an investigator-led clinical development study at Skåne University Hospital
An investigator-led clinical development study has started at Skåne University Hospital in Malmö. In this context, the first examination of resected rectal cancer tissue has been performed with the NanoEcho diagnostic system.
Scientific evidence for NanoEcho’s imaging method
An image of magnetic nanoparticles in human tissue generated by magnetomotive ultrasound is shown for the first time. The image created with NanoEcho’s prototype system in the ongoing investigator-led study at Sahlgrenska University Hospital has now been published in a peer-reviewed article (1).
NanoEcho Strengthens its Regulatory Competence
As part of the company’s development, NanoEcho is strengthening the organisation by adding regulatory expertise to the management team. Kristina Hallström will bear responsibility for Quality Assurance and Regulatory Affairs, with a particular focus on market approval for NanoEcho’s system.
Board member resigns at his own request due to medical reasons
At his own request, BG (Bengt-Göran) Svensson has chosen to leave NanoEcho’s board for medical reasons. At the same time, he announces that he is leaving all of his board assignments.
NanoEcho announces collaboration partner for the nanoparticle
NanoEcho and SPL medical have signed a Letter of Intent and initiated a cooperation on regulatory partnership and supply for the iron-oxide based nanoparticle. The aim of the collaboration is to achieve market approval for the NanoEcho indication, diagnostics of rectal cancer lymph node metastases.
Go ahead to start clinical development study at Skåne University Hospital in Malmö
NanoEcho has been cleared to start a clinical development study at Skåne University Hospital in Malmö. The ethics committee has already approved the study and recruitment of patients is planned to commence during the fall.
NanoEcho and us4us have signed a letter of intent
NanoEcho has chosen the supplier us4us and started collaboration around the development and future manufacturing of the imaging device.
A new Board has been appointed at NanoEcho – increased focus on commercialization
A new Board that reflects the Company’s development has been appointed. The newly appointed Chairman is Daniel Johnsson, former CEO and founder of, among others, Exertis Nordics, now investor and advisor. A new member of the Company’s Board is PhD and Business Coach Ann-Christin Malmborg Hager.